Jahnsen, J. (2016). Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients. Therap Adv Gastroenterol.
Chicago Style CitationJahnsen, Jørgen. "Clinical Experience With Infliximab Biosimilar Remsima (CT-P13) in Inflammatory Bowel Disease Patients." Therap Adv Gastroenterol 2016.
Cita MLAJahnsen, Jørgen. "Clinical Experience With Infliximab Biosimilar Remsima (CT-P13) in Inflammatory Bowel Disease Patients." Therap Adv Gastroenterol 2016.
Atenció: Aquestes cites poden no estar 100% correctes.